- Home
- Applications
- faroe islands
- tumor mutation
Show results for
Refine by
Tumor Mutation Product Applications Available In Faroe Islands
1 applications found
Unfortunately, this benefit does not extend to patients whose tumors contain mutations in EGFR signaling components KRAS and BRAF, which together represent 50% of all colorectal cancers. ...
ByBiocept based in San Diego, CALIFORNIA (USA)
